INTRODUCTION
Hydralazine ( Figure 1 ) is a prototype of 'lupus-inducing drugs' that elicit anti-nuclear antibodies and a syndrome resembling systemic lupus erythematosus in recipients [1] [2] [3] . This adverse effect has reduced its usage as an antihypertensive drug, at least with larger doses. Among the anti-nuclear antibodies elicited by hydralazine, anti-histone antibodies are the most prominent; however, antibodies reacting with single-stranded and Z-DNA are also found in the serum of patients taking this drug [4] [5] [6] . The origin of these antibodies in the serum of drug-treated patients is not known at present. Several studies, including those from our laboratory, indicated the possible interactions of hydralazine and other lupus-inducing drugs with DNA [7] [8] [9] . Sequence and conformational specificity has been observed in these interactions. Our results have specifically revealed that hydralazine binds with high affinity to DNA sequences capable of assuming the Z-DNA conformation [5] . Potential Z-DNA-forming alternating purine-pyrimidine sequences are widely dispersed in native DNAs and their frequency of occurrence is far higher in DNA isolated from the serum of lupus patients compared with normal controls [10, 11] . As Z-DNA is immunogenic [12, 13] , we examined whether the serum of hydralazine-treated patients contained antibodies reacting with this conformation of DNA; we found significantly higher levels of Z-DNA-binding antibodies in 82 % of patients compared with normal controls [5] . These results indicate a possible mechanism involving the induction and stabilization of immunogenic Z-DNA in hydralazine-treated patients.
formational perturbations of DNA in the presence of spermidine and hydralazine. These results support the hypothesis that hydralazine is capable of stabilizing unusual forms of DNA. In contrast with the weak immunogenicity of DNA in its righthanded B-DNA conformation, these unusual forms are immunogenic and have the potential to elicit anti-DNA antibodies. To test this possibility, we analysed sera from a panel of 25 hydralazine-treated patients for anti-(triplex DNA) a-ntibodies using an ELISA. Our results showed that 72% of sera from hydralazine-treated patients contained antibodies reacting toward the triplex DNA. In contrast, there was no significant binding of normal human sera to triplex DNA. Taken together our data indicate that hydralazine and related drugs might exert their action by interacting with DNA and stabilizing higherorder structures such as the triplex DNA.
Triplex DNA has attained much attention in recent years because of its potential use as an anti-gene strategy for treating cancer and immunological disorders, as well as its potential in genome mapping [14] [15] [16] [17] . Triplex-DNA-forming poly-(purine) * poly(pyrimidine) sequences are widely dispersed in the human genome [18] . Triplex DNA can form in vivo either by the binding of an oligonucleotide to a continuous stretch of purines or pyrimidines or as a part of H-DNA (hinge DNA) which consists of folded regions of triple-and single-stranded DNA. The presence of multivalent cations such as Mg2+ or spermine is essential for triplex-DNA stabilization at physiological pH. We have demonstrated a structural specificity for polyamines in triplex-DNA stabilization [19] . This result is particularly important because of the ubiquitous nature of these molecules and their up-regulation in lupus and related autoimmune diseases [20] [21] [22] [23] .
Triplex DNA is weakly immunogenic, and monoclonal and polyclonal anti-(triplex DNA) antibodies have been raised [24, 25] . Burkholder et al. [26] have also found the presence of triplex DNA in chromosomal-loop regions by using fluorescence antibody. On the basis of these results, we questioned whether hydralazine is capable of inducing and/or stabilizing triplex DNA in labile sequences. We therefore examined the effect of low concentrations of hydralazine on the melting temperature Tm of duplex and triplex forms of poly(dA) * poly(dT) and found that hydralazine only has a destabilizing effect on All patients were without known immunological or significant cardiac disease. Nine of the patients were male, of whom four were Caucasian and five black, and 16 were black females. The mean age was 39.9 (range 17-55 years). All patients were admitted to the General Clinical Research Center (GCRC) for prehydralazine study and were re-admitted for evaluation at yearly intervals. During the initial admission at the GCRC, routine laboratory studies were completed and the acetylation phenotype was determined using sulphamethazine [28, 29] on those patients who had a negative history for allergic reactions to sulphonamides. After release from the GCRC, the patients were followed in the clinic. Hydralazine was used as the major antihypertensive at doses of less than 400 mg/day. Ten patients received 40 mg/ day hydralazine, six 300 mg/day, two 200 mg/day and seven 150 mg/day as maintenance therapy.
We also used sera from 29 age-matched normal individuals as controls. The mean age of the group was 39.1 (range 23-55 years). 
Tm measurement
Absorbance versus temperature heating curves were obtained using a Perkin-Elmer Lambda 2 spectrophotometer [19, 30, 31] . The temperature of the five-cell holder was regulated by a thermoelectrically controlled programmer interfaced to an IBM PS2 computer. Melting profiles were obtained by increasing the temperature at a rate of 0.5°C per min, with the absorbance and temperature being recorded every 30 s. Tm was taken as the temperatures corresponding to halfdissociation of the complexes and the reproducibility was within + 0.5 'C. The first derivative, dA/dT (where A is absorbance and T is temperature), of the melting curve was computer-generated and was also used to determine Tm of the triplex (Tm ) and duplex (Tm2) forms of the polynucleotides. Tm values obtained from the two methods did not differ by more than 0.5 'C.
Measurement of CD spectra CD spectra of poly(dA) and poly(dT) in 1: 1 and 1: 2 ratio in the presence and absence of spermidine and/or hydralazine were recorded using an AVIV model 62DS CD spectrophotometer. We used a 1 cm quartz cuvette for spectral measurements.
Analysis of sera for antibodies reacting wih triplex DNA Serum samples were collected at the University of Cincinnati Medical Center from hypertensive patients treated with hydralazine over a period of several years, as indicated above. In some cases sequential samples were collected, and in others samples were obtained at single points. These samples were analysed for anti-(triplex DNA) antibodies using a published ELISA procedure [32] . A spermidine-stabilized triplex DNA form of poly(dA) 2poly(dT) was used as an authentic form of triplex DNA. A duplex form of the same polynucleotides was further used to compare the binding of the sera between the different forms. Microtitre plates were coated with poly(dA) . 2poly(dT) triplex formed in the presence of 25 uM spermidine at a concentration of 10 tg/ml, washed and then treated with serum samples of hydralazine recipients or normal controls at a dilution of 1:400 (200,ug/well). The wells were treatments did not produce antibodies reacting with DNA [27] .
subsequently treated with peroxidase-conjugated affinity-purified goat anti-human polyclonal antibodies and the enzyme substrate, o-phenylenediamine. The enzyme-substrate reaction was stopped by the addition of 50 ,A of2.5 M H2SO4/well, and the absorbance was read at 490 nm with a microplate autoreader (Molecular Devices, Palo Alto, CA, U.S.A.).
As a control, we also measured the binding of sera from hydralazine-treated patients to the double-stranded form of calf thymus DNA, by methods described previously [5] .
Analysis of anti-(single-stranded DNA) antibodies In the sera of hydralazine-treated patients
We also analysed the sera from hydralazine recipients and control subjects for the presence of anti-(single-stranded DNA) antibodies using an ELISA technique [32] . In this case, heatdenatured calf thymus DNA was used as a source of singlestranded DNA. The ELISA protocol was similar to that employed to detect anti-(triplex DNA) antibodies. 
The method of continuous fractions (UV mixing curves) was used to examine the formation of duplex and triplex DNAs from poly(dA)-2poly(dT) in the presence of spermidine and/or hydralazine [19] . An inflection point at 0.5 mol fraction representing duplex DNA formation was observed both in the absence and presence of2.5 ,tM spermidine and/or 50 ,uM hydralazine (results not shown). However, when triplex formation was examined by this method using molar fractions of the duplex DNA and a third strand of poly(dT), an inflection point representing the triplex formation was obtained only in the presence of spermidine or in the presence of spermidine and hydralazine. In order to characterize the stabilization of triplex DNA by hydralazine further, we determined the Tm of different combinations of spermidine and/or hydralazine with a Perkin-Elmer Lambda 2 UV/visible spectrophotometer.
The absorbance-temperature profile and the first derivative (dA/dT) of poly(dA) and poly(dT) mixed in 1:2 ratio in 10 mM sodium cacodylate buffer are shown in Figure 2(a) . A sharp increase in absorbance centred at 55.3°C was found, indicating the melting transition of double-helical polynucleotide. In the temperature range of 22-95°C, there was no additional melting transition, and hence the polynucleotides existed in the duplex form even when poly(dA) and poly(dT) were mixed in a 1:2 ratio. In separate experiments, we also found that duplex DNA formed from poly(dA) *poly(dT) by mixing the polynucleotides in 1:1 ratio melted at 55.3 +0.2 'C. Figure 2(b) shows the absorbance-temperature profile and derivative curve of poly(dA) -poly(dT) in the presence of 250 ,uM hydralazine. We used this concentration because previous experiments showed that 250 #M hydralazine exerted optimal interaction with DNA and shifted the conformation of poly(dGm5dC) *poly(dG-m5dC) to the Z-DNA form. In the presence of hydralazine, the polynucleotide melted at 52.5 'C, a temperature slightly lower than the Tm of poly(dA) poly(dT) in the absence of hydralazine. This result is consistent with previous studies by [7] and others showing a destabilization of duplex DNA by hydralazine [33] .
In the next set of experiments, we examined whether hydralazine is capable of interacting with triplex DNA. We used 2.5 ,M spermidine to stabilize the triplex form of poly(dA) -2poly(dT). In Figure 3(a) , we show the absorbancetemperature profile of poly(dA) 2poly(dT) in the presence of 10 mM sodium cacodylate buffer containing 2.5 ,uM spermidine.
There are two melting transitions in this case, the first centred at 42.8°C, and the second at 65.4 'C. We designated the first melting transition as T , corresponding to the melting of poly(dA) -2poly(dT) to duplex poly(dA) -poly(dT) and singlestranded poly(dT). The second melting transition (Tm.) corresponds to the melting of duplex DNA in the presence of spermidine. It is interesting to note that spermidine increased Tm by 12.9 'C. In order to confirm that this increase was due to the stabilizing effect of spermidine on the duplex form of poly(dA) -poly(dT), we determined the effect of spermidine on the Tm of authentic poly(dA) * poly(dT). Our results are presented in Table 1 . Spermidine has a dose-dependent stabilizing effect on the Tm of duplex DNA. The addition of 250 FM hydralazine to poly(dA) -2poly(dT) triplex had a significant effect on Tm and Tm as shown in Figure   3 (b). The increases in Tm, and Tm in the presence of hydralazine were 10.8 and 0.8°C respectively. Thus hydralazine exerted a remarkable stabilizing effect on the triplex form of poly(dA -2poly(dT) even in the absence of a marked effect on the Tm of duplex DNA. There was also a significant increase in the amplitude of the Tm peak in the presence of hydralazine, suggesting structural aiterations in triplex DNA stabilized by this drug. We further examined the dose-dependent effect of hydralazine on the Tm of triplex DNA formed in the presence of both spermidine and Mg2+. There was a significant effect of hydralazine on the stability of triplex DNA formed in the presence of these two cations (Table 2) .
We next recorded the CD spectra of poly(dA) -poly(dT) in 1: 1 and 1:2 ratio in the presence of different concentrations of spermidine (Figures 4a and 4b ). In the duplex form, poly(dA) * poly(dT) had two negative bands at 205 and 246 nm, and three positive peaks at 217, 260 and 282 nm (Figure 4a ). The intensity of the 282 nm peak was slightly lower than that of the 260 nm peak for duplex DNA. At a concentration of 2.5 ,uM, spermidine had only a minor effect on reducing the intensity of the 282 nm positive peak and in provoking a negative band at 268 nm, whereas 25 ,uM spermidine caused a reduction in the peak intensity of both the positive band at 217 nm and the negative band at 246 nm. In addition, the positive band at 260 nm was eliminated and a broad positive band centred at 280 nm was formed. The distinctive feature of poly(dA) and poly(dT) mixed in 1 :2 molar ratio was the complete disappearance of the 217 nm positive band and the appearance of a strong negative band centred at 212 nm (Figure 4b) . With the addition of spermidine, the intensity of this band sharpened with a shift in the peak maxima to 217 nm. This negative band is considered to be a characteristic feature of triplex DNA [31] . There were no major alterations in the nature or intensity of other bands. Addition of hydralazine to poly(dA) 2poly(dT) in the presence of 2.5 FM spermidine slightly reduced the peak intensity and caused the appearance of a second negative peak at wavelengths below 200 nm (Figure 4c ). The alterations in the CD spectra of poly(dA) poly(dT) and poly(dA) 2poly(dT) in the presence of spermidine as a single agent or spermidine and hydralazine in combination indicated conformational alterations caused by these ligands in duplex and triplex DNA. UV melting experiments further indicated that these conformational transitions were associated with the stabilization of the duplex-and triplex-DNA structures.
Hydralazine is known to elicit antibodies reacting with histones, single-stranded DNA and Z-DNA in patients treated with this drug. The molecular basis of anti-nuclear antibody production by hydralazine is not as yet clear. As triplex DNA was reported to be immunogenic, we next examined whether serum from patients treated with hydralazine contained antibodies reactive with this form of DNA. To accomplish this, we used an ELISA protocol used in our previous studies [32] . Microtitre plates were coated with the triplex form of poly(dA) * 2poly(dT) in the presence of 50 ,uM spermidine to test for the presence of anti-(triplex DNA) antibodies. Polynucleotides in 1:1 molar ratio (duplex) were used as a control. Furthermore, the binding of sera to single-stranded DNA was also studied. Table 3 presents the results of our ELISA experiments. Absorbance values obtained for the binding of sera from hydralazine-treated patients and controls to different forms of DNA show significant differences in the binding of the sera to these forms. Sera from normal controls exhibited only negligible binding to double-and single-stranded forms of calf thymus DNA. There was considerable binding of these sera to the duplex form of poly(dA) -poly(dT), which might be due to its ability to adopt unusual structures [33] . Sera from hydralazine-treated patients showed greater binding to the triplex form of the polynucleotides, and the mean binding of the sera to the duplex form of the same polynucleotides was significantly less (P < 0.002). Although these sera exhibited detectable binding to single-stranded calf thymus DNA, the mean absorbance value was 7-fold lower than that to the triplex form of poly(dA) * 2poly(dT). The [7, 34] , this drug caused slight destabilization of the duplex form of poly(dA) poly(dT), whereas a 10.8°C increase in the Tm of the triplex form of poly(dA) * 2poly(dT) was found. Both duplex and triplex forms of the polynucleotides were also stabilized by spermidine and Mg2+.
The mechanism of binding of hydralazine to duplex and triplex forms of DNA is not known at present. Earlier studies by Dubroff and Reid [8] showed that hydralazine could covalently interact with thymidine and deoxycytidine, and hydralazine adducts of these bases were isolated by HPLC. An intercalative mode of binding of hydralazine to DNA was proposed by Sinha and Patterson [9] who found strong binding of this drug to DNA. In this context it is interesting to note that Scaria and Shafer [31] found that a well-known DNA intercalator, ethidium bromide, stabilized the triplex form of poly(dA) *2poly(dT) in the buffer conditions used in our experiment. Since the third strand in triplex DNA binds through the major groove of DNA, this groove may become relatively unavailable for accommodation of the drug. Thus triplex DNA may bind through the minor groove of DNA or via intercalation of the drug molecule between DNA bases. Alternatively, hydralazine binding to triplex DNA might be governed by electrostatic interaction between the positively charged amino group of hydralazine and the negative phosphate groups on DNA. As in the case of the binding of polyamines to DNA [35] [36] [37] , both modes of interaction may be operative, providing sequence specificity in the binding of hydralazine to DNA.
Although triplex DNA has been described in the literature for more than three decades [38, 39] , its biological relevance and potential therapeutic implications have come to the forefront of DNA structural chemistry only recently [40, 41] . Triplex-forming sequences consisting of purine-pyrimidine tracts are present in the regulatory regions of several genes, including c-myc [42] , interleukin 2 receptor [43] and DNA polymerase a [44] , and represent up to 1 % of certain eukaryotic genome [18] . Only a limited number of ligands have been demonstrated to stabilize triplex DNA. These include polyamines [19, [45] [46] [47] , MgCl2 [14] [15] [16] [17] , ethidium bromide [31] and benzo[e]pyridoindole derivatives [48] . Our recent studies [19] demonstrate the ability of polyamines to stabilize triplex DNA and the importance of ionic and structural factors necessary to provoke this form. In the present study, we demonstrate that triplex DNA induced by polyamines can be further stabilized by agents such as hydralazine, a drug that appears to affect the conformational and structural stability of DNA. As spermidine and other polyamines are natural constituents of the cells [20] , and their levels are high in disease states [49] , it is possible that polyamines induce triplex-DNA formation in serum where nucleosome-length DNA fragments are formed by drug action or other mechanisms. Thus the discovery of hydralazine-induced stabilization of triplex DNA is an important step in understanding the nature of agents that stabilize this form of DNA. Our serological analysis of 25 hydralazine-treated patients shows that the majority of sera collected at different time points contain antibodies reacting with the triplex form of poly(dA) -2poly(dT). The mean absorbance indicating binding of sera to triplex DNA is 3-fold higher than the binding of the same sera to the duplex DNA form of the same polynucleotides (A = 1.095+1.01 compared with 0.492+0.37; n = 65; P = 0.002). Binding of these sera to single-stranded calf thymus DNA is very low (A = 0.15 + 0.16). Previous studies showed that their binding to double-stranded calf thymus DNA was also negligible, whereas they exhibited high levels of binding toward the Z-DNA form of polynucleotides [5] . Increased binding of hydralazinerelated sera to the duplex form of the polynucleotides might be a consequence of disproportionation of the polynucleotides toward the triplex form in the presence of the protamine sulphate used to achieve nucleic acid binding on microtitre plates. The affinity of these antibodies for unusual forms of DNA (triplex and Z-DNA) suggests that these forms could have acted as immunogenic stimuli and elicited these antibodies.
In summary, we provide evidence for high-affinity binding and stabilization of poly(dA) 2poly(dT) by hydralazine, a drug frequently associated with anti-nuclear antibody production in treated patients. We also show that the majority of sera from a panel of hydralazine-treated patients exhibited high-affinity binding for the triplex form of poly(dA) * 2poly(dT). The binding of these sera to the same polynucleotides was significantly lower in the absence of a triplex-stabilizing ligand. These data suggest that a possible mechanism for anti-nuclear antibody production in hydralazine-treated patients might involve the induction and stabilization of immunogenic forms of DNA, including higherorder structures such as triplex DNA.
